Corporation Acclaro Medical Secures $23 Million in Series B Funding to Drive Innovation and Global ExpansionMay 29, 2025 Acclaro Medical announces successful completion of Series B funding round led by Accelmed Partners with participation from 3E Bioventures Capital, totaling $23 million